BIOMAT Database Logo BIOMAT Database Logo

FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. 1998

H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Department of General Surgery, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.

BACKGROUND In the experiment described here, we investigated the effects of the immunosuppressants FK506 and leflunomide (Lef) on the survival of hamster hearts and liver xenografts in Lewis rats. METHODS Lewis rats were used as recipients of hamster heart or liver grafts using different regimens of FK506 and Lef. Donor-matched heart grafts were transplanted into long-term surviving Lewis rat recipients of hamster xenografts to test donor-specific prolongation of xenograft survival. Hyperimmune, late xenograft rejection, and naive sera were transferred into long-term surviving Lewis rat recipients of hamster heart xenografts to determine whether these sera could inhibit the efficacy of donor-specific long-term survival. Anti-donor-specific antibodies were analyzed by flow cytometry. RESULTS After a short induction with FK506 plus Lef, maintenance treatment with FK506 alone was sufficient to prolong survival of hamster xenografts. All hamster heart and four of six hamster liver xenografts survived for more than 3 months. Second hamster hearts were permanently accepted by Lewis rats bearing long-term surviving hamster heart xenografts when rats were treated with FK506 monotherapy (mean survival time >60 days, n=4). Long-term surviving hamster heart grafts were rejected after transfer of hyperimmune serum but not late xenograft rejection serum or naive serum. Lef and FK506 significantly reduced the production of anti-donor-specific antibodies in Lewis rats transplanted with hamster liver and heart xenografts. CONCLUSIONS Long-term survival of hamster liver and heart xenografts in Lewis rats could be induced by a regimen of short-term FK506 in combination with Lef followed by FK506 monotherapy. The acquired sensitivity of late xenoreactivity to FK506 reflects primarily a modification in the host immune response to the hamster graft.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008297 Male Males
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft

Related Publications

H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
February 1995, Transplantation proceedings,
H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs.
April 1993, Transplantation,
H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Effect of RS61443 in combination with leflunomide or FK506 on rat heart allograft survival.
January 1996, Transplant international : official journal of the European Society for Organ Transplantation,
H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin.
March 1993, Transplantation,
H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Acute xenograft rejection, late xenograft rejection and long term survival xenografts in the hamster-to-rat heart transplantation model: histological characterisation under low-dose of FK506.
October 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine.
December 1994, Transplantation proceedings,
H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Prolongation of cardiac xenograft survival in a hamster-to-rat combination by recipient treatment with deoxymethylspergualin.
November 1993, Transplantation,
H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Hamster cardiac xenograft in rat ear: effect of cyclosporine A and leflunomide on survival.
January 1996, International journal of immunopharmacology,
H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Characteristics of mouse to rat xenograft heart transplantation.
January 1990, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
H N Sankary, and D P Yin, and A S Chong, and L L Ma, and L Blinder, and J K Shen, and P Foster, and J W Williams
Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
April 1996, Transplantation proceedings,
Copied contents to your clipboard!